Copy this embed code to put a Tinker widget on your site or blog!
Embed
Set Widget Options
Select Type:
Widget
Badge
Select Color:
Select Size:
Display Options:
Select Badge:
Preview:
Takeda, Amylin to co-develop obesity drugs
November 1, 2009
Reuters : 19 days ago Read Full Story >>
TOKYO (Reuters) - Japan's Takeda Pharmaceutical and U.S. Amylin Pharmaceuticals said on Monday they will co-develop and commercialize drugs to treat obesity, including two Amylin drugs in mid-stage trials.
Trend Report
Trend Chart
ActiveX component must be enabled.
Line chart viewable with Flash Player v.8 or higher.
Line chart viewable with Flash Player v.8 or higher.
Top Trends
Related Topics ()
- Moderate Democrat boosts Senate health bill
Created: 20 hours ago - Funeral workers risk cancer from formaldehyde
Created: 21 hours ago - Los Angeles gets tough on medical marijuana shops
Created: 21 hours ago - Eat and drink your way to a healthy colon?
Created: 22 hours ago - Swine flu may be peaking in U.S.
Created: 22 hours ago
Get Tnkr.in URL grab a shorter link
Link to this Stream
RSS feed of Takeda, Amylin to co-develop obesity drugs's updates
